Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$518M |
| 2 |
Procter & Gamble
PG
|
+$413M |
| 3 |
Merck
MRK
|
+$354M |
| 4 |
Amazon
AMZN
|
+$331M |
| 5 |
Hasbro
HAS
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$458M |
| 2 |
CELG
Celgene Corp
CELG
|
+$415M |
| 3 |
Mastercard
MA
|
+$305M |
| 4 |
Intuitive Surgical
ISRG
|
+$304M |
| 5 |
PayPal
PYPL
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Healthcare | 17.13% |
| 3 | Financials | 11.91% |
| 4 | Industrials | 10.9% |
| 5 | Consumer Discretionary | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Baxter International
BAX
$11.6B
| $221M | 0.11% |
2,640,819
-764,464
| -22% | -$63.3M |
|
202
Stanley Black & Decker
SWK
$14.2B
| $221M | 0.11% |
1,330,501
-411,000
| -24% | -$63.6M |
|
203
Donaldson
DCI
$10.8B
| $220M | 0.11% |
3,810,482
-12,724
| -0.3% | -$692K |
|
204
AutoZone
AZO
$48.3B
| $219M | 0.11% |
183,762
-96,291
| -34% | -$111M |
|
205
Automatic Data Processing
ADP
$100B
| $219M | 0.11% |
1,283,449
-657,467
| -34% | -$109M |
|
|
PRAH
206
DELISTED
PRA Health Sciences, Inc.
PRAH
| $218M | 0.11% |
1,960,897
+200,498
| +11% | +$20.6M |
|
207
EOG Resources
EOG
$78B
| $215M | 0.11% |
2,566,928
-199,648
| -7% | -$14.6M |
|
208
Lockheed Martin
LMT
$134B
| $215M | 0.11% |
551,677
-9,179
| -2% | -$3.52M |
|
|
HZNP
209
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $213M | 0.11% |
+5,875,619
| New | +$180M |
|
|
IAA
210
DELISTED
IAA, Inc. Common Stock
IAA
| $211M | 0.11% |
4,485,655
+258,349
| +6% | +$10.9M |
|
211
Cadence Design Systems
CDNS
$90B
| $210M | 0.11% |
3,026,797
-2,254,586
| -43% | -$151M |
|
212
Fastenal
FAST
$54B
| $209M | 0.11% |
11,307,148
+6,360,698
| +129% | +$114M |
|
213
Wayfair
W
$11.1B
| $207M | 0.11% |
2,285,189
-30,217
| -1% | -$2.82M |
|
214
Sempra
SRE
$60.8B
| $203M | 0.1% |
2,682,864
+305,300
| +13% | +$22.4M |
|
215
NRG Energy
NRG
$29.8B
| $196M | 0.1% |
4,920,194
-2,480,373
| -34% | -$98.1M |
|
|
AGN
216
DELISTED
Allergan plc
AGN
| $195M | 0.1% |
1,019,935
-345,944
| -25% | -$62.4M |
|
217
Etsy
ETSY
$7.65B
| $194M | 0.1% |
4,389,338
+1,951,377
| +80% | +$93M |
|
|
SUM
218
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $193M | 0.1% |
8,216,584
-721,569
| -8% | -$16.4M |
|
219
McCormick & Company Non-Voting
MKC
$13.4B
| $193M | 0.1% |
2,273,092
-876,184
| -28% | -$72.5M |
|
220
Ball Corp
BALL
$17B
| $191M | 0.1% |
2,954,281
-1,181,402
| -29% | -$80.1M |
|
221
Micron Technology
MU
$1.04T
| $191M | 0.1% |
3,550,571
-165,841
| -4% | -$7.92M |
|
|
AXON
222
Axon Enterprise
AXON
$40.5B
| $191M | 0.1% |
2,600,214
+299,281
| +13% | +$18.9M |
|
223
Bruker
BRKR
$9.2B
| $190M | 0.1% |
3,729,050
-7,445
| -0.2% | -$354K |
|
224
Union Pacific
UNP
$183B
| $190M | 0.1% |
1,051,445
-259,813
| -20% | -$44.5M |
|
225
Ligand Pharmaceuticals
LGND
$6.02B
| $190M | 0.1% |
2,913,411
+403,078
| +16% | +$26.9M |
|
Similar funds
Janus Henderson Group's Q4 2019 Portfolio in Review
As of Q4 2019, Janus Henderson Group held 1,494 positions worth $195B, up 5.8% from $185B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Janus Henderson Group's Q4 2019 filing shows 96 new, 553 increased, 735 reduced and 82 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 5,875,619 shares worth $213M. The largest sale was Walt Disney, an estimated $458M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q4 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 5,875,619 shares worth $213M.
- Janus Henderson Group added most to Meta Platforms (Facebook) in Q4 2019, an estimated $518M increase.
- Janus Henderson Group's biggest Q4 2019 reduction was Walt Disney, cutting an estimated $458M.
- Janus Henderson Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
- Janus Henderson Group's ten largest holdings make up 18% of its $195B portfolio in Q4 2019.
- Janus Henderson Group opened 96 new positions and closed 82 in Q4 2019.
- Janus Henderson Group's portfolio value rose 5.8% quarter-over-quarter to $195B.
Based on Janus Henderson Group's 13F filing for Q4 2019, filed 18 Feb 2020.